Mr. Viehbacher first broached the idea of a deal with Mr. Termeer on May 23, according to the filing. Mr. Termeer suggested they wait to talk until after a proxy fight the company was then waging against Carl Icahn. After a June agreement handed the activist investor two Genzyme board seats, Mr. Viehbacher approached Mr. Termeer again June 28.